Auranofin

In some countries, this medicine may only be approved for veterinary use.

In the US, Auranofin (auranofin systemic) is a member of the drug class antirheumatics and is used to treat Felty's Syndrome, Pemphigus, Psoriatic Arthritis and Rheumatoid Arthritis.

US matches:

• Auranofin

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

M01CB03

CAS registry number (Chemical Abstracts Service)

0034031-32-8

Chemical Formula

C20-H34-Au-O9-P-S

Molecular Weight

678

Therapeutic Categories

Anti-inflammatory agent

Disease-modifying antirheumatic drug, DMARD

Chemical Name

Gold, (1-thio-ß-D-glucopyranose 2,3,4,6-tetraacetato-S)(triethylphosphine)-

Foreign Names

• Auranofinum (Latin)
• Auranofin (German)
• Auranofine (French)
• Auranofina (Spanish)

Generic Names

• Auranofin (OS: USAN, JAN, DCIT, BAN)
• Auranofine (OS: DCF)
• SKF D-39162 (IS)

Brand Names

• Auropan
  Krka, Georgia



• Goldar
  Zydus Cadila, India



• Grelyse
  Daito, Japan



• Ridaura
  Astellas, Belgium; Astellas, United Kingdom; GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Iran; GlaxoSmithKline, Japan; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Qatar; Goldshield, Austria; Goldshield, Australia; Goldshield, Denmark; Goldshield, Finland; Goldshield, Hong Kong; Goldshield, Ireland; Goldshield, Israel; Goldshield, Norway; Goldshield, New Zealand; Prometheus, United States



• Ridaura (veterinary use)
  Astellas, United Kingdom



• Ridauran
  Pierre Fabre Médicament, France



• Rizast
  Medisa Shinyaku, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.